Bayesian Network Meta-Analysis (Nma) to Assess Relative Efficacy of Canagliflozin (Cana) Versus Glucagon-Like Peptide-1 (Glp-1) Agonists in Dual and Triple Therapy In Patients with type 2 Diabetes Mellitus (T2dm)
May 1, 2015, 00:00
10.1016/j.jval.2015.03.319
https://www.valueinhealthjournal.com/article/S1098-3015(15)00376-9/fulltext
Title :
Bayesian Network Meta-Analysis (Nma) to Assess Relative Efficacy of Canagliflozin (Cana) Versus Glucagon-Like Peptide-1 (Glp-1) Agonists in Dual and Triple Therapy In Patients with type 2 Diabetes Mellitus (T2dm)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)00376-9&doi=10.1016/j.jval.2015.03.319
First page :
A54
Section Title :
Diabetes/Endocrine Disorders
Open access? :
No
Section Order :
1414